Editor's Correspondence |

Preattack Vaccination Against Anthrax May Be Cost-effective in Certain Populations

Robert J. Hopkins, MD, MPH, TM; Thomas A. Waytes, MD, PhD; Thomas K. Zink, MD
Arch Intern Med. 2008;168(1):114-115. doi:10.1001/archinternmed.2007.27.
Text Size: A A A
Published online


Schmitt et al1 report that preexposure anthrax vaccination of US Postal Service (USPS) employees is more costly and results in more anthrax infections and deaths than postattack intervention. We believe that these conclusions are incorrect owing to a flawed study design and several questionable parameter estimates.

The most important flaw is the assumption that unvaccinated workers would be denied antibiotics after an attack, especially when 50% adherence to preattack vaccination is presumed. If instead these workers were modeled to receive antibiotics, quality-adjusted life years (QALYs) gained preventing anthrax cases would exceed QALYs lost to vaccine adverse events. Based on the presented incidence, duration and quality-of-life effects of vaccine adverse effects, 0.0000148 QALYs are lost per vaccination series. With a 50% adherence assumption, 2.6 QALYs would be lost because of adverse events. If one assumes that preexposure vaccination is 92.5% effective and considering the data in Table 3 of the article by Schmitt et al,1 a strategy providing antibiotics to exposed but unvaccinated workers would reduce anthrax cases and deaths by 39% (2.4 and 0.7, respectively), providing a gain in QALYs far outweighing QALYs lost to vaccine adverse events. These improved health outcomes can only be assigned to the addition of preattack vaccination to a postattack intervention using antibiotics. Adding postexposure vaccination for these workers would reduce cases and deaths and further improve QALYs gained.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles